DMAAU
Drugs Made In America Acquisition Corp.
NASDAQ · Financial Services · Financial - Conglomerates · US
$10.91
−0.82%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 55.58x
- PEG TTM
- —
- Price / book
- 2.65x
- Price / sales
- —
- Price / cash flow
- -1131.66x
Enterprise value
- Enterprise value
- $366.6M
- EV / sales
- —
- EV / EBITDA
- -139.21x
- EV / EBIT
- -139.21x
- Market cap
- $365.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026